Drugs by condition
Drugs approved for menopause symptoms
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
21
Still marketed, NDA or BLA
Drug classes
4
Novel drugs
4
New molecular entities and new biologics
In development
1
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for menopause symptoms.
- Lynkuet (Elinzanetant) · Bayer Hlthcare NovelOct 24, 2025
- Veozah (Fezolinetant) · Astellas NovelPriority reviewMay 12, 2023
- Duavee (Bazedoxifene Acetate, Estrogens, Conjugated) · Wyeth Pharms NovelOct 3, 2013
- Brisdelle (Paroxetine Mesylate) · Legacy Jun 28, 2013
- Minivelle (Estradiol) · Noven Oct 29, 2012
All approved drugs for menopause symptoms, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 33 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Estrogen (13)
- Duavee Bazedoxifene Acetate, Estrogens, Conjugated · Wyeth Pharms · 2013
- Premarin Estrogens, Conjugated · Wyeth Pharms · 1942
- Minivelle Estradiol · Noven · 2012
- Evamist Estradiol · Padagis US · 2007
- Divigel Estradiol · Vertical Pharms · 2007
- Elestrin Estradiol · Viatris · 2006
- Estrogel Estradiol · Ascend Theraps US · 2004
- Climara Pro Estradiol, Levonorgestrel · Bayer Hlthcare · 2003
- Activella Estradiol, Norethindrone Acetate · Amneal · 1998
- Combipatch Estradiol, Norethindrone Acetate · Noven Pharms INC · 1998
- Estradiol Estradiol · Sandoz · 1996
- Prempro Estrogens, Conjugated, Medroxyprogesterone Acetate · Wyeth Pharms · 1995
- Climara Estradiol · Bayer Hlthcare · 1994
Neurokinin 3 Receptor Antagonist (1)
- Veozah Fezolinetant · Astellas · 2023
Progestin (1)
- Angeliq Drospirenone, Estradiol · Bayer Hlthcare · 2005
Class not listed in FDA's data (6)
- Lynkuet Elinzanetant · Bayer Hlthcare · 2025
- Brisdelle Paroxetine Mesylate · Legacy · 2013
- Femring Estradiol Acetate · Millicent Mfg Pr · 2003
- Lupron Depot Leuprolide Acetate · Abbvie Endocrine INC · 1997
- Lupron Depot Leuprolide Acetate · Abbvie Endocrine INC · 1990
- Delestrogen Estradiol Valerate · Ph Health · 1954
Drugs in development for menopause symptoms
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- ABCL635Phase 21 trial
AbCellera Biologics Inc. · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
More on menopause symptoms: recruiting trials · published research
Related in endocrinology and women's health: Hypothyroidism · Osteoporosis · Endometriosis · Uterine fibroids · Birth control · Low testosterone · Growth hormone deficiency · Acromegaly · Cushing's syndrome
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.